Pharmacology
DrugBankDescription
Kratom (Mitragyna speciosa) is a medicinal plant species from Southeast Asia. It’s a member of the coffee family (Rubiaceae). Like coffee, kratom is a central nervous system stimulant used to increase energy and productivity. However, the effects of kratom are highly dose-dependent. In lower doses, it’s a stimulant but in higher doses, the effects flip-flop and become sedative instead. As a result, there are a few different reasons someone may want to use kratom. In smaller doses, it’s used much like coffee — as a stimulant and nootropic for use at work or university. In higher doses, kratom is used as an alternative to alcohol (not recommended) for its euphoric effects, to promote sleep, and as an alternative to opiate painkillers. Many of the active ingredients in kratom are powerful opiate agonists — which means they bind to the opioid receptors to block the transmission of pain signals from the body to the brain. This also triggers the release of the feel-good neurotransmitter, dopamine. People addicted to opiates use kratom to wean themselves off the drugs. The effects of kratom help alleviate withdrawal symptoms while undergoing detox for prescription or illicit opiates (more on this later). Kratom is not particularly dangerous, but there are risks to using it. While far less addictive compared to prescription painkillers, kratom is still an opiate. Over time, the body can become dependent on its effects and become addicted.
Receptor Profile
Receptor Actions
History & Culture
Kratom is indigenous to Cambodia, Thailand, Indonesia, Malaysia, Myanmar, and Papua New Guinea, where its leaves have been used in traditional herbal medicine since at least the nineteenth century. The plant has historically been consumed through chewing, smoking, and preparation as a tea. In Thailand, kratom served important social and ceremonial functions, being used as a snack to receive guests and as part of ritual worship of ancestors and gods. The substance was also valued for its practical applications; by 1836, it was reported to be used as an opium substitute in Malaysia, and similar use was documented in Thailand throughout the nineteenth century. Historically, its effects at low doses have been compared to those of coca, while higher doses have been likened to opium.
1839–1859
Mitragyna speciosa was first formally described by the Dutch colonial botanist Pieter Korthals in 1839, who initially named it Stephegyne speciosa. The plant underwent several reclassifications before George Darby Haviland established its current taxonomic name and classification in 1859.
2010–present
Beginning in the 2010s, a tea-based preparation known as "4×100" emerged as a popular recreational drink among young people across Southeast Asia, particularly in Thailand. This cocktail combines kratom leaves with cough syrup, Coca-Cola, and ice. By around 2011, individuals who consumed this preparation were generally viewed more negatively than traditional kratom users, though not as stigmatized as users of substances like heroin. In Western contexts, kratom has gained attention as a self-treatment option for opioid withdrawal, with many individuals using it to ease the transition away from opioid dependence. It has also been occasionally cited as an aid for addressing acute alcohol dependency.
Subjective Effect Notes
physical: The physical effects of kratom can be broken down into several components which progressively intensify proportional to dosage.
cognitive: The cognitive effects of kratom can be broken down into several components which progressively intensify proportional to dosage.
sensory: The visual effects of kratom are unusually strong compared to other opioids of its class. They can be broken down into several components which progressively intensify proportional to dosage.
Effect Profile
Curated + 645 ReportsStrong euphoria and focus with moderate stimulation, mild anxiety/jitters
Strong euphoria, itching/nausea, pain relief, and sedation
Empirical Duration
Erowid ReportsCommunity Effects
TripSitTolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Cross-Tolerances
Demographics
Gender Distribution
Age Distribution
Reports Over Time
Effect Analysis
Erowid + BluelightEffects aggregated from 609 experience reports (559 Erowid + 86 Bluelight)
Effect Sentiment Distribution
Confidence Distribution
Positive Effects 50
Adverse Effects 40
Subjective Effect Ontology
Experience ReportsStructured effect tags extracted from 645 Erowid & Bluelight experience reports using a controlled vocabulary of 220+ canonical effects across 15 domains.
Auditory
Cognitive
Emotional
Gastrointestinal
Motor
Tactile
Dosage Distribution
Dose distribution from experience reports
Real-World Dose Distribution
62K DosesFrom 738 individual dose entries
Oral (n=527)
Smoked (n=5)
Common Combinations
Most co-occurring substances in experience reports
Form / Preparation
Most common forms and preparations reported
Body-Weight Dosing
Dose relative to body weight from reports with weight data
Redose Patterns
Redosing behavior across 477 reports
Legal Status
| Country | Status | Notes |
|---|---|---|
| United Kingdom | Controlled (Psychoactive Substances Act 2016) | Supply and import were prohibited prior to 2016. The Psychoactive Substances Act 2016 subsequently captured kratom under its blanket ban on psychoactive substances, making production, supply, and import illegal. Notably, this legislation was enacted despite kratom being used by some individuals as an aid for opioid withdrawal and alcohol dependency. |
References
Cited References
- Chemical composition and biological effects of kratom (Scientific Reports)
- Drug Users Bible: Kratom
- Erowid: Kratom Basics
- Erowid: Kratom Dose
- Erowid: Kratom Health
- Erowid: Kratom Vault
- EUDA: Kratom Drug Profile
- Kratom—Pharmacology, Clinical Implications, and Outlook (PMC)
- PubChem: Mitragynine
- PsychonautWiki: Kratom
- The Chemical and Pharmacological Properties of Mitragynine (PMC)
- TripSit Factsheet: Kratom
- TripSit Factsheet: Kratom